Skip to content
Search

Latest Stories

'Dwindling margins' are making pharmacies untenable

Lack of appropriate funding is making survival a massive challenge for community pharmacy, a sector relied upon as a vital support system by both primary and secondary care in England.

The Telegraph newspaper ran a story on Monday (August 22) which highlighted the dire straits community pharmacy finds itself in. Seasoned pharmacist Ian Strachan told the paper: “Our four pharmacies were the only point of call that was open (during Covid). We were there every single day, even when the virus was prevalent and people were dying.”


Describing the current situation, he said: “What is happening is we're facing a system that's just not working at all in our favour.” Strachan says the issue is that pharmacists are “just not getting the help we need to be able to do this job properly”.

The sector is hugely dependent on funding from the NHS. The government had agreed in 2019 to set £2.6bn as annual funding for the sector. However, according to a report from EY that amount was already down £200m on the 2016 levels of government funding.

“We've been starved of appropriate funding since 2016,” Dr Leyla Hannbeck, chief executive of the Association of Independent Multiple Pharmacies told The Telegraph. “It looks grim for businesses. The fees pharmacists get are going nowhere, but now, there’s higher utility bills, higher staff fees and higher drug costs.”

The paper cited another challenge faced by Paul Mason, a superintendent pharmacist at the Yorkshire pharmacy group Lo’s Pharmacy. Mason said he was looking for one item yesterday “and the cheapest price” he could get the stock for was at least "20 times what the NHS drug tariff was listing”.

“If I’d bought it, I’d be losing £20 a box on that one. It’s just not reasonable."

Mason stated that with such “dwindling margins it is difficult to reward our staff appropriately in the current environment".

“It is heartbreaking for me,” Hannbeck told The Telegraph. “I’m hearing members say that they have put everything into their pharmacy to make sure that they’re providing healthcare in communities, particularly in areas of high deprivation, and then they're in a position where they have to sell their house to survive.”

On the funding situation, The Telegraph also quoted Boots pharmacy director Anne Higgins as saying, “is not sustainable in the long term and, like the rest of the sector, we want to work with the government to address this”.

Data from the PSNC shows that over 639 local pharmacies have been lost in England since 2016. In July, two dozen parliamentarians from across the political spectrum called on the prime minister to act as a wave of pharmacy closures in recent years has threatened to spiral out of control.

A letter to the prime minister signed by 24 MPs and peers has warned that worse could be yet to come after “spiralling business costs” and “year after year of real terms funding cuts” have led to hundreds of pharmacy closures.

“Because the thing is, all the obvious costs have gone up,” told Gareth Jones, the NPA’s director of corporate affairs to the Telegraph. “There are all those same costs you'd expect any business to have to shoulder and there is no ability to increase prices, to respond to this sort of situation, because of the way the sector is heavily reliant on NHS funding from the government.”

“We can be the solution for the NHS,” Hannbeck told The Telegraph. “We can provide those services to cut the number of people going to A&E”. But, in her view, “you can’t just add these extra things on and not pay. We just can't be treated like that."

According to the EY report, the situation might worsen as data suggested in 2020 that 60 per cent of pharmacies would be loss-making by 2021, which may rise even further, to 72 per cent by 2024.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less